Menarini News

The acquisition of US company Stemline Therapeutics: a brave move that rewards Menarini at M&A Award 2021

2020 has been an unprecedentedly arduous year around the world. Many industrial sectors – including pharmaceuticals and healthcare – have been affected by the pandemic. In such a delicate context, undertaking a $677 million operation by purchasing 100% of the shares of a major US biopharmaceutical company was a bold move, that allowed Menarini Group []

trending_flat Read more